PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.\', \'HOPES Research Group, UConn and Hartford Hospital, Hartford, Connecticut, USA.\', \'Rubicon Global Enterprises & Colombo Plan Secretariat, Huachuca City, Arizona, USA.\', \'Bertino Consulting, Schenectady, New York, USA.\', \'Department of Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jcph.1860
?:hasPublicationType
?:journal
  • Journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34396559
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.997
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of Abuse.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34396559>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34396559>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all